Peter Lindsay

Background

About Peter Lindsay

Practices in the Washington, DC office of Paul Hastings and focuses on advising clients regarding a range of regulatory, compliance, and enforcement issues relevant to life sciences companies. Conducts significant internal reviews for companies addressing promotional activities, FDA post-market requirements, GXP activities, safety reporting, and fraud and abuse considerations. Supports crisis management strategy and helping companies address recalls and other significant market actions. Advises companies in government investigations involving criminal and civil issues regarding alleged violations of the federal Food, Drug, and Cosmetic Act, the federal Anti-Kickback Statute, and the federal False Claims Act. Counsels many clients across the FDA-regulated product spectrum, including medical devices, pharmaceutical manufacturers (API and drug product), and biotech companies. This support has included advising companies on many aspects of the product life cycle from development, clinical trials, commercialization, and post-market enforcement. Also assists in corporate transactions by conducting regulatory due diligence on FDA-related matters. This material may be considered attorney advertising under certain rules of professional attorney conduct. No attorney-client relationship is created when you contact me.